MASH
Metabolic dysfunction-associated steatohepatitis. The inflammatory subset of MASLD. Formerly NASH. Target indication for semaglutide and retatrutide.
Metabolic dysfunction-associated steatohepatitis. The inflammatory subset of MASLD. Formerly NASH. Target indication for semaglutide and retatrutide.